1. Natural Products
  2. Plants
  3. Polyporaceae
  4. Ganoderma lucidum (Leyss. Ex Fr.) Karst.

Ganoderma lucidum (Leyss. Ex Fr.) Karst.

Synonyms: Lingzhi

Ganoderma lucidum (Leyss. Ex Fr.) Karst. (44):

Cat. No. Product Name CAS No. Purity Chemical Structure
  • HY-N1511
    Ganoderic acid D 108340-60-9 99.18%
    Ganoderic acid D, a highly oxygenated tetracyclic triterpenoid, is the major active component of Ganoderma lucidum. Ganoderic acid D upregulates the protein expression of SIRT3 and induces the deacetylated cyclophilin D (CypD) by SIRT3. Ganoderic acid D inhibits the energy reprogramming of colon cancer cells including glucose uptake, lactate production, pyruvate and acetyl-coenzyme production in colon cancer cells. Ganoderic acid D induces HeLa human cervical carcinoma apoptosis.
    Ganoderic acid D
  • HY-N1447
    Ganoderic acid A 81907-62-2 99.20%
    Ganoderic acid A can inhibit of the JAK-STAT3 signaling pathway, also inhibit proliferation, viability, ROS.
    Ganoderic acid A
  • HY-N1517
    Ganoderic acid C2 103773-62-2 99.30%
    Ganoderic acid C2 is a bioactive triterpenoid in Ganoderma lucidum. Ganoderic acid C2 possesses the potential anti-tumor bioactivity, antihistamine, anti-aging and cytotoxic effects. Ganoderic acid C2 exhibits high inhibitory activity against the rat lens aldose reductase (RLAR) with an IC50 of 3.8 µM.
    Ganoderic acid C2
  • HY-N9312
    Ganoderic acid J 100440-26-4 98.27%
    Ganoderic acid J is a natural terpenoid isolated from the Fungus Ganoderma lucidum. Ganoderic acid J possesses anti-inflammatory anti-inflammatory activity.
    Ganoderic acid J
  • HY-N2006
    Ganoderic acid B 81907-61-1 99.31%
    Ganoderic acid B is a triterpene isolated from a mushroom Ganoderma lucidum. Ganoderic acid B inhibits the activation of Epstein-Barr virus (EBV) antigens as telomerase inhibitor. Ganoderic acid B is a moderately active inhibitor against HIV-1 protease.
    Ganoderic acid B
  • HY-N10119
    Ganoderterpene A 2682180-85-2
    Ganoderterpene A attenuates LPS-induced inflammation and apoptosis via suppressing MAPK and TLR-4/NF-κB pathways in BV-2 cells.
    Ganoderterpene A
  • HY-107259
    23S-Hydroxyl-11,15-dioxo-ganoderic acid DM 1085273-49-9
    23S-Hydroxyl-11,15-dioxo-ganoderic acid DM is a compound isolated from the fruit bodies of Ganoderma lucidum.
    23S-Hydroxyl-11,15-dioxo-ganoderic acid DM
  • HY-N1513
    Ganoderic acid H 98665-19-1
    Ganoderic acid H is a lanostane-type triterpene isolated from Ganoderma lucidum. Ganoderic acid H suppresses growth and invasive behavior of breast cancer cells through the inhibition of transcription factors AP-1 and NF-kappaB signaling.
    Ganoderic acid H
  • HY-N9350
    Ganoderic acid ε 294674-05-8 98.62%
    Ganoderic acid ε is a natural terpenoid isolated from the Fungus Ganoderma lucidum. Ganoderic acid ε exhibits an ED50 of 12.2 μg/mL in Meth-A tumor cells
    Ganoderic acid ε
  • HY-N2997
    Ganoderic acid LM2 508182-41-0 99.59%
    Ganoderic acid LM2 is a natural terpenoid isolated from the Fungus Ganoderma lucidum. Ganoderic acid LM2 possesses potential anti-tumor activity.
    Ganoderic acid LM2
  • HY-125361
    Ganosporeric acid A 135357-25-4
    Ganosporeric acid A, a natural product, is isolated from the ether-soluble fraction of the spores of Ganoderma lucidum (Curt.: Fr.) P. Karst. Ganosporeric acid A can be used for the research of liver injury.
    Ganosporeric acid A
  • HY-N6036
    Ganoderic acid F 98665-15-7 99.00%
    Ganoderic acid F is a ganoderic acid. Ganoderic acid F exhibits antitumor and antimetastatic activities through inhibition of angiogenesis and alteration of proteins involving cell proliferation and/or cell death, carcinogenesis, oxidative stress, calcium signaling, and endoplasmic reticulum stress.
    Ganoderic acid F
  • HY-N3500
    Ganoderic acid D2 97653-94-6 99.18%
    Ganoderic acid D2 (compound 27) is a triterpenoid isolated from Ganoderma lucidum. Ganoderic acid D2 has anticancer, anti-inflammatory and antioxidative activity.
    Ganoderic acid D2
  • HY-120140
    Ganoderic acid DM 173075-45-1 99.65%
    Ganoderic acid DM, a natural triterpenoid isolated from Ganoderma lucidum, induces DNA damage, G1 cell cycle arrest and apoptosis in human breast cancer cells. Ganoderic acid DM as a specific inhibitor of osteoclastogenesis.
    Ganoderic acid DM
  • HY-129150
    Ganoderic acid TR 862893-75-2 ≥98.0%
    Ganoderic acid TR is a broad-spectrum inhibitor against influenza neuraminidases (NAs), particularly H5N1 and H1N1 neuraminidases. The IC50 values of 10.9 and 4.6 μM, respectively.
    Ganoderic acid TR
  • HY-N2458
    Ganoderic acid G 98665-22-6 98.15%
    Ganoderic acid G is a triterpene isolated from the surface part of gills of Ganoderma lucidum.
    Ganoderic acid G
  • HY-129151
    Ganoderic acid C1 95311-97-0
    Ganoderic acid C1, a natural compound that could be isolated from G. lucidum, suppresses TNF-α production by murine macrophages (RAW 264.7 cells).
    Ganoderic acid C1
  • HY-N6861
    Lucidenic acid B 95311-95-8
    Lucidenic acid B is a natural compound isolated from Ganoderma lucidum, induces apoptosis of cancer cells, and causes the activation of caspase-9 and caspase-3, and cleavage of PARP. Lucidenic acid B does not affect the cell cycle profile, or the number of necrotic cells.
    Lucidenic acid B
  • HY-125713
    Ganoderic acid Y 86377-52-8 99.07%
    Ganoderic acid Y is a α-glucosidase inhibitor with an IC50 of 170 μM for yeast α-glucosidase. Ganoderic acid Y inhibits enterovirus 71 (EV71) replication through blocking EV71 uncoating.
    Ganoderic acid Y
  • HY-107260
    Lucidenic acid D 98665-16-8 99.47%
    Lucidenic acid D (Lucidenic acid D2) is a highly oxidized lanostane-type triterpenoid.
    Lucidenic acid D